TRIS-NAC- acetylcysteine solution
Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
deionized water, EDTA, ethylhexylglycerin, PEG-40 hydrogenated castor oil, phenoxyethanol, propylene glycol, silica, Tris.
Tris-NAC™ is an innovative and synergistic combination of NAC and Tris-EDTA to be applied as an effective support to prevent bacterial biofilm formation. Where a mature biofilm already exists, Tris-NAC™ works to disrupt it and break it down.
How to use:
In the ear canal: dispense the contents of the syringe into the ear canal and gently massage the base of the ear. On the skin: soak a sterile gauze with the product and hold the gauze to the skin for at least 2 minutes. In the case of larger areas, put the product directly on the skin until completely soaked. In both cases, do not rinse or dry. Repeat the application when necessary, or as your veterinarian directs.
See the package leaflet for further information.
Nextmune US, LLC
2801 S. 35th St., Phoenix,
AZ 85034 - 480-464-8971
a division of nextmune
NEXTMUNE ITALY S.R.L.
Via G.B. Benzoni, 50 26020
PALAZZO PIGNANO (CR) Italy
Tel. +39 0373 982024 +39 0373 938345
e-mail: firstname.lastname@example.org - email@example.com
|Labeler - Nextmune AB (352950223)|
|NEXTMUNE Italy SRL||435856461||MANUFACTURE|
|PharmaZell GmbH||506639652||API MANUFACTURE|